FDA regulation of the new drug "Serc" : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-second Congress, second session /

Oversight of the new drug review process and FDA's regulation of Merital : hearing before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-ninth Congress, second session, May 22, 1986.
Published: (1987)

FDA's regulation of Zomax : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-eighth Congress, first session, April 26 and 27, 1983.
Published: (1983)

FDA drug bulletin.
Published: (1971)

"Man-in-the-plant", FDA's failure to regulate deceptive drug labeling : hearings before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session, September 8 and 12, 1978.
Published: (1978)

FDA consumer protection activities--FDA reorganization : hearings, Ninety-first Congress, first and second session ...
Published: (1970)

The Food and Drug Administration (FDA) /
Published: (2003)

The regulation of new drugs by the Food and Drug Administration : the new drug review process : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-seventh Congress, second session, August 3 and 4, 1982.
Published: (1982)

Drugs@FDA.

Problems with FDA's regulation of the antiarrhythmic drugs Tambocor and Enkaid : hearing before the Human Resources and Intergovernmental Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, first session, April 10, 1991.
Published: (1992)

Modernizing FDA's regulation of over-the-counter drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fifteenth Congress, first session. September 13, 2017.
Published: (2018)

FDA drug approval : review time has decreased in recent years : report to congressional requesters.
Published: (1995)

Council on Competitiveness and FDA plans to alter the drug approval process at FDA : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, March 19, 1992.
Published: (1993)

FDA regulation of over-the-counter (OTC) drugs : overview and issues for Congress /
by: Bodie, Agata
Published: (2021)

FDA and the drug development process : how the agency ensures that drugs are safe and effective.
Published: (2002)

The FDA /
by: Lucas, Scott, 1937-
Published: (1978)

FDA : safeguarding America's health.
Published: (1990)

FDA-approved bargain drugs : generic products must meet high standards.
Published: (2003)

FDA's regulation of animal drug residues in milk : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred First Congress, second session, February 6, 1990.
Published: (1990)

FDA oversight--food inspection : hearings, Ninety-second Congress, first session ...
Published: (1972)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

Allegations of FDA abuses of authority : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, first session, July 25, November 15, and December 5, 1995.
Published: (1996)

FDA's review process for new drug applications : a management review.
Published: (2003)

Problems with FDA monitoring for animal drug residues : is our milk safe? : hearing before the Human Resources and Intergovernmental Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred Second Congress, second session, August 5, 1992.
Published: (1993)

FDA's foreign drug inspection program : weaknesses place Americans at risk : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, second session, April 22, 2008.
Published: (2008)

Science at the FDA : the mainstay of public health protection, new technology is FDA's greatest challenge.
Published: (2002)

The FDA prescription drug file.
Published: (1991)

Off-label drug use and FDA review of supplemental drug applications : hearing before the Subcommittee on Human Resources and Intergovernmental Relations of the Committee on Government Reform and Oversight, House of Representatives, One Hundred Fourth Congress, second session, September 12, 1996.
Published: (1997)

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [as printed] meets standards for safety and efficacy, March 1, 2005.
Published: (2005)

FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [as printed] meets standards for safety and efficacy, March 1, 2005.
Published: (2005)

FDA's generic drug approval process : hearings before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred First Congress, first session.
Published: (1989)

FDA's generic drug application policy : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundredth Congress, second session, July 28, 1988.
Published: (1989)

Challenges for the FDA : the future of drug safety : workshop summary /
Published: (2007)

FDA reform legislation : hearings before the Subcommittee on Health and Environment of the Committee on Commerce, House of Representatives, One Hundred Fourth Congress, second session, on H.R. 3199, 3200, and 3201, May 1 and 2, 1996.
Published: (1996)

FDA foreign drug inspection program : a system at risk : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, November 1, 2007.
Published: (2008)

FDA foreign drug inspection program : a system at risk : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, November 1, 2007.
Published: (2008)

FDA policy on home drug testing kits : hearing before the Subcommittee on Oversight and Investigations of the Committee on Commerce, House of Representatives, One Hundred Fifth Congress, first session, February 6, 1997.
Published: (1997)